The 2026 annual meeting of stockholders was held virtually on May 6, 2026. Stockholders elected John McCutcheon and Dr. Bronwyn Evans as Class II directors to serve until 2029. Approval was granted for the addition of 18,010,366 shares of common stock to the 2021 Equity Incentive Plan. Stockholders approved various option grants for directors, including John McCutcheon, Allan Will, Karen Drexler, Trevor Moody, Dr. David Steinhaus, Dr. Bronwyn Evans, and Dr. Chris Nave.